LONDON (Reuters) -AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England, citing a cut in British government support.
The pharmaceutical giant said it was no longer pursuing a £450 million investment in a vaccine manufacturing plant in ...